Clinical trial
Docetaxel in Treating Older Patients With Locally Advanced or Metastatic…
NCT00227708 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00227708 |
|---|---|
| Title | Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer |
| Official title | Phase II Trial Assessing the Impact on Instrumental and Daily Living Autonomy of a Chemotherapy Regimen With Bi-Weekly Docetaxel in the Treatment of Metastatic or Locally Advanced Non-Small Cell Lung Cancer in Patients Over the Age of 70 |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Procedure |
| Interventions | docetaxel, quality-of-life assessment |
| Enrollment | 58 |
| Start date | Jun 1, 2005 |
| Completion | Aug 29, 2006 |
| First posted | Sep 28, 2005 |
| Last update posted | Feb 13, 2020 |
| Countries | France, Switzerland, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: